Patent · US Active

Nucleic acid molecules encoding novel herpes antigens, vaccine comprising the same, and methods of use thereof

US9243041B2 · kind B2 · utility

10Cited by
56References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 31, 2012
Grant dateJan 26, 2016
Priority date
Expiry dateJan 31, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2710/16734
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are nucleic acid sequences that encode novel consensus amino acid sequences of herpes virus antigens, as well as genetic constructs/vectors and vaccines expressing the sequences. Also provided herein are methods for generating an immune response against herpes virus using the vaccines that are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.